Unique ID issued by UMIN | UMIN000050538 |
---|---|
Receipt number | R000057555 |
Scientific Title | Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study |
Date of disclosure of the study information | 2023/03/08 |
Last modified on | 2024/02/10 09:31:10 |
Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study
JSTM-PROS01HR
Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study
JSTM-PROS01HR
Japan |
Prostate cancer
Urology | Radiology |
Malignancy
NO
To determine treatment efficacy, adverse events, and heating feasibility in hyperthermia combined radiotherapy for high-risk prostate cancer through a multicenter prospective registry of patient data.
Safety,Efficacy
5-year biochemical recurrence-free survival rate
3/5/8-year overall/cause-specific /clinical recurrence-free survival rate, Adverse event rate, Transitions in the IPSS and QOL scores
Observational
20 | years-old | <= |
Not applicable |
Male
1) Patients diagnosed with high-risk prostate cancer
2) Patients undergoing radiotherapy and hyperthermia
3) Patients who are 20 years of age or older at the time of enrollment
4) Patients with an ECOG Performance Status (PS) of 0 to 2
5) Patients expected to survive more than 3 months
1) Patients with multiple cancers (simultaneous multiple cancers or iatrogenic multiple cancers with a disease-free interval of 5 years or less).However, intraepithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer are not included in overlapping cancers.
2) Patients who have a history of irradiation (re-irradiation) at the same site as the current irradiation.
3) Patients who will be treated with three-dimensional source body irradiation
4) Patients who will not receive concomitant endocrine therapy
5) Patients who are scheduled to receive concomitant small source radiation therapy
6) Patients who are judged by the principal investigator to be inappropriate for enrollment in this study.
200
1st name | Makoto |
Middle name | |
Last name | Ito |
Aichi Medical University Hospital
Radiology
480-1103
1-1 Yazako-Karimata, Nagakute, Aichi
0561-62-3311
itou.makoto.292@mail.aichi-med-u.ac.jp
1st name | Makoto |
Middle name | |
Last name | Ito |
Aichi Medical University Hospital
Radiology
480-1103
1-1 Yazako-Karimata, Nagakute, Aichi
0561-62-3311
itou.makoto.292@mail.aichi-med-u.ac.jp
Aichi Medical University
Makoto Ito
Self-funding
Self funding
Aichi Medical University /Faculty of Medicine Ethics Committee
1-1 Yazako-Karimata, Nagakute, Aichi
0561-62-3311
amu_ethics@aichi-med-u.ac.jp
NO
愛知医科大学病院(愛知県)/ Aichi Medical University Hospital(Aichi)
群馬大学数理データ科学教育研究センター (群馬県)/ Gunma University Center for Mathematics and Data Science (Gunma)
産業医科大学病院(福岡県)/ University of Occupational and Environmental Health(Fukuoka)
弘前大学医学部附属病院 (青森県)/ Hirosaki University Hospital (Aomori)
名古屋市立大学病院(愛知県)/ Nagoya City University Hospital (Aichi)
久留米大学病院(福岡県)/ Kurume University Hospital(Fukuoka)
総合大雄会病院(愛知県)/ Daiyukai General Hospital(Aichi)
厚生連高岡病院(富山県)/ Kouseiren Takaoka Hospital(Toyama)
総合南東北病院/南東北がん陽子線治療センター(福島県)/Southern Tohoku General Hospital/Southern Tohoku Proton Therapy Center
2023 | Year | 03 | Month | 08 | Day |
Unpublished
Open public recruiting
2022 | Year | 12 | Month | 26 | Day |
2023 | Year | 02 | Month | 06 | Day |
2023 | Year | 03 | Month | 08 | Day |
2026 | Year | 06 | Month | 30 | Day |
None
2023 | Year | 03 | Month | 08 | Day |
2024 | Year | 02 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057555